Grandfather and granddaughter in a field

Targeted Therapy Delivered

Lisata Therapeutics is a clinical-stage pharmaceutical company developing innovative therapies based on clear differentiation and rigorous data applied in areas of high unmet medical need.

Learn more about our approach
Hand of male or female putting jigsaw puzzle connecting on woodden desk, Strategic management and business solutions for success


In a webinar hosted by FORCE Family Office, Lisata’s President & CEO, David Mazzo, PhD, discusses U.S. FDA Rare Pediatric Disease Designation for osteosarcoma as well as Fast Track and Orphan Drug Designations in Pancreatic Ductal Adenocarcinoma and Glioblastoma Multiforme for LSTA1. 


LSTA1 Mechanism of Action Explanation Video


Treating Pancreatic Tumors: Drug Delivery Systems & Pancreatic Cancer

Dr. Sugahara joined Dr. Hyesoo Lowe on an episode of Columbia Surgery’s podcast Conversations and Curbsides. The two doctors discuss the difficulty of treating pancreatic cancer tumors, and how drug delivery systems can potentially improve both chemotherapy and immunotherapy.


Cell therapy scientist looking through a microscope

Broad, Clinical-Stage Pipeline

We aim to transform patient lives through the development of unique therapies targeting cancer and other serious diseases.

Join Our Team

Our mission is to discover, develop and deliver innovative therapies for the treatment of advanced solid tumors and other major diseases. We can accomplish that goal through the collective efforts of talented individuals who work together to advance scientific research. We place a premium on integrity, respect, diversity, and collaboration. These values have helped us to build a growing company that offers professionally rewarding careers with the opportunity to make a meaningful contribution to patients in need.

Lisata career interviewer reviewing a candidates resume